论文部分内容阅读
目的:当患者发生急性心肌梗塞心力衰竭时,分析卡维地洛辅助治疗的临床效果。方法:根据2013年4月到2014年5月我院收诊的150例急性心肌梗塞心力衰竭的具体情况作为主要观察对象,无顺序的抽取75例为一组,分别记录为A组和B组。在之后的治疗中,经家属同意后对A组实行常规治疗加卡维地洛辅助治疗,而B组只进行常规治疗。经过相同治疗时间后,将两组患者临床数据进行汇总对比分析。结果:进行卡维地洛辅助治疗的患者在左心室舒张末容积指数、收缩膜容积指数以及射血分数上都要优于B组,并且不良反应发生概率小于B组,均具有统计学意义(P<0.05)。结论:卡维地洛辅助治疗急性心肌梗塞心力衰竭的临床效果显著,可一定程度上改善心功能,是一种不错的治疗药物。
Objective: To analyze the clinical effect of adjunctive therapy with carvedilol in patients with heart failure due to acute myocardial infarction. Methods: According to the clinical data of 150 cases of acute myocardial infarction admitted from April 2013 to May 2014 in our hospital, 75 patients were randomly selected as group A and group B respectively . In the subsequent treatment, after the consent of the family member, group A received routine treatment plus carvedilol adjuvant therapy, while group B received only routine treatment. After the same treatment time, the clinical data of two groups were pooled and compared. Results: The patients with carvedilol adjuvant therapy were superior to group B in left ventricular end-diastolic volume index, contractile membrane volume index and ejection fraction, and the incidence of adverse reactions was less than that of group B (all statistically significant ( P <0.05). Conclusion: Carvedilol adjuvant treatment of acute myocardial infarction with significant clinical effect of heart failure, to some extent, improve cardiac function, is a good therapeutic drug.